SCHEMBL2935245

SCHEMBL2935245

CN(C)c1cnc2c(Oc3ccc(NC(=O)O)c(F)c3)ccnc2n1

nearest known ligand 0.72

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRAF P15056 19/20 0.72
KDR P35968 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3756503 0.88 BRAF (0.70) BRAFKDR
SCHEMBL2926476 0.85 BRAF (0.54) BRAF
SCHEMBL2932117 0.84 BRAF (1.00) BRAF
SCHEMBL3754105 0.81 BRAF (1.00) BRAF
SCHEMBL3759454 0.80 BRAF (0.57) BRAF
SCHEMBL2936229 0.79 BRAF (0.48) BRAFKDR
SCHEMBL2935779 0.78 BRAF (0.75) BRAFKDR
SCHEMBL16740695 0.76 BRAF (0.70) BRAF
SCHEMBL3756160 0.75 BRAF (0.55) BRAFKDR
SCHEMBL3761432 0.74 BRAF (0.69) BRAFKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229391-A1 PYRIDO[2,3-B]PYRAZINE-8-SUBSTITUTED COMPOUNDS AND THEIR USE Cancer Research Technology Limited (GB) 2010-09-22 EP disclosed
WO-2009077766-A1 PYRIDO[2,3-B]PYRAZINE-8-SUBSTITUTED COMPOUNDS AND THEIR USE CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2009-06-25 WO disclosed